ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Sage Therapeutics, Inc.
1. SAGE is under investigation for potential securities law violations. 2. The company is involved in a proposed acquisition by Supernus Pharmaceuticals. 3. Stockholders will receive $8.50 plus a contingent value right worth up to $3.50. 4. The transaction is valued between $561 million and $795 million. 5. The acquisition is expected to close in Q3 2025.